Adamis Pharma Buy Hold or Sell Recommendation

ADMPDelisted Stock  USD 1.74  0.24  12.12%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Adamis Pharma is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Adamis Pharma given historical horizon and risk tolerance towards Adamis Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Adamis Pharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Note, we conduct extensive research on individual companies such as Adamis and provide practical buy, sell, or hold advice based on investors' constraints. Adamis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Execute Adamis Pharma Buy or Sell Advice

The Adamis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Adamis Pharma. Macroaxis does not own or have any residual interests in Adamis Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Adamis Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Adamis PharmaBuy Adamis Pharma
Not Rated
For the selected time horizon Adamis Pharma has a Risk Adjusted Performance of (0.19), Jensen Alpha of (1.74), Total Risk Alpha of (2.85) and Treynor Ratio of 5.66
We provide trade advice to complement the prevailing expert consensus on Adamis Pharma. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Adamis Pharma is not overpriced, please confirm all Adamis Pharma fundamentals, including its cash and equivalents, number of employees, and the relationship between the price to sales and book value per share . Please also double-check Adamis Pharma price to earning to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Adamis Pharma Trading Alerts and Improvement Suggestions

Adamis Pharma is not yet fully synchronised with the market data
Adamis Pharma may become a speculative penny stock
Adamis Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 4.76 M. Net Loss for the year was (26.48 M) with loss before overhead, payroll, taxes, and interest of (1.43 M).
Adamis Pharma currently holds about 8.88 M in cash with (25.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.

Adamis Pharma Returns Distribution Density

The distribution of Adamis Pharma's historical returns is an attempt to chart the uncertainty of Adamis Pharma's future price movements. The chart of the probability distribution of Adamis Pharma daily returns describes the distribution of returns around its average expected value. We use Adamis Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Adamis Pharma returns is essential to provide solid investment advice for Adamis Pharma.
Mean Return
-1.77
Value At Risk
-11.6
Potential Upside
8.72
Standard Deviation
6.84
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Adamis Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Versi Ebrahim of 8745 shares of Adamis Pharma subject to Rule 16b-3 [view details]

Adamis Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Adamis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Adamis Pharma Buy or Sell Advice

When is the right time to buy or sell Adamis Pharma? Buying financial instruments such as Adamis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Adamis Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Blend Funds Thematic Idea Now

Small Blend Funds
Small Blend Funds Theme
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Adamis Stock

If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities